Zura Bio Newsroom

H.C. Wainwright Maintains Zura Bio(ZURA.US) With Hold Rating, Maintains Target Price $5

Futu NewsNov 19 16:39

Zura Bio Analyst Ratings

BenzingaNov 18 19:17

H.C. Wainwright Maintains Zura Bio(ZURA.US) With Hold Rating, Maintains Target Price $5

Futu NewsNov 11 20:34

Cautious Outlook on Zura Bio: Neutral Rating Due to Clinical Challenges and Financial Uncertainty

TipRanksNov 11 19:40

Chardan Capital Maintains Zura Bio(ZURA.US) With Buy Rating, Cuts Target Price to $12

Futu NewsNov 9 22:31

Guggenheim Maintains Zura Bio(ZURA.US) With Buy Rating, Cuts Target Price to $15

Futu NewsNov 9 21:31

Zura Bio Price Target Cut to $12.00/Share From $14.00 by Chardan Capital

Dow JonesNov 9 08:18

Zura Bio Is Maintained at Buy by Chardan Capital

Dow JonesNov 9 08:18

Zura Bio Analyst Ratings

BenzingaNov 9 08:08

Leerink Partners Maintains Zura Bio(ZURA.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 6 20:33

Piper Sandler Maintains Zura Bio(ZURA.US) With Buy Rating, Maintains Target Price $26

Futu NewsNov 5 20:31

Leerink Partners Initiates Zura Bio(ZURA.US) With Buy Rating, Announces Target Price $15

Futu NewsNov 4 20:35

Zura Bio Analyst Ratings

BenzingaNov 4 20:07

Zura Bio's Strategic Positioning and Promising Asset Portfolio: A Buy Recommendation by Analyst Faisal Khurshid

TipRanksNov 4 19:45

Piper Sandler Maintains Zura Bio(ZURA.US) With Buy Rating, Maintains Target Price $26

Futu NewsOct 28 19:31

Analysts' Opinions Are Mixed on These Healthcare Stocks: Universal Health (UHS), Apellis Pharmaceuticals (APLS) and Zura Bio (ZURA)

TipRanksOct 28 18:53

Zura Bio's Leadership Instability and Uncertain Prospects Lead to Hold Rating

TipRanksOct 21 18:31

H.C. Wainwright Maintains Zura Bio(ZURA.US) With Hold Rating, Maintains Target Price $5

Futu NewsOct 21 18:31

HC Wainwright & Co. Reiterates Neutral on Zura Bio, Maintains $5 Price Target

BenzingaOct 21 18:27

Zura Bio Analyst Ratings

BenzingaOct 18 20:19